“Half-Life-Extended Monoclonal Antibody APG777 for Atopic Dermatitis: Design of the Phase 2 APEX Study”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s456. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/3074.